High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea · Delayed Price · Currency is KRW 11,750
+300 (2.62%)
At close: Aug 14, 2026
High Tech Pharm Market Cap
High Tech Pharm has a market cap or net worth of 124.94 billion as of August 14, 2026. Its market cap has decreased by -5.47% in one year.
Market Cap
124.94B
Enterprise Value
116.49B
Revenue
69.05B
Ranking
n/a
PE Ratio
13.93
Stock Price
11,750.00
ChartMarket Cap Chart
Since July 28, 2010, High Tech Pharm's market cap has increased from 96.60B to 124.94B, an increase of 29.34%. That is a compound annual growth rate of 1.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 124.94B | -2.25% |
| Dec 30, 2025 | 127.81B | -14.14% |
| Dec 30, 2024 | 148.86B | 50.05% |
| Dec 28, 2023 | 99.21B | 28.39% |
| Dec 29, 2022 | 77.27B | -20.44% |
| Dec 30, 2021 | 97.12B | -25.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 172.67B |
| GC WellBeing | 166.27B |
| Ahn-Gook Pharmaceutical | 142.29B |
| Kyung Dong Pharmaceutical | 138.48B |
| PHARMARESEARCH BIO | 131.69B |
| HYUNDAI BIOLAND | 117.30B |
| DongKoo Bio & Pharma | 106.41B |
| OPTUS Pharmaceutical | 105.88B |